Active Secondary Progressive Multiple Sclerosis Clinical Trial
Official title:
Impact of Mayzent (Siponimod) on Active Secondary Progressive Multiple Sclerosis Patients in a Long-term Non-interventional Study in Italy
This is an observational, multicenter, single-arm, prospective study conducted in Italy
Primary data will be collected over a period of three years. Medical history of participants will be collected including EDSS, MRI outcomes, relapses and previous medication to allow the estimation of the effects of siponimod treatment on an individual basis. ;